Simultaneous overexpression of multidrug efflux pumps in Pseudomonas aeruginosa non-cystic fibrosis clinical isolates
The purpose of this study was to examine expression and regulation of 6 multidrug efflux systems, including MexAB-OprM, MexCD-OprJ, MexEF-OprN, MexXY, MexJK, and MexVW, in 13 non-cystic fibrosis (CF) clinical isolates of Pseudomonas aeruginosa. These isolates displayed a high level of resistance to many clinically important antibiotics. Some isolates simultaneously overexpressed up to 4 different Mex systems, as determined by quantitative real-time reverse transcription PCR. None of the isolates overexpressed MexCD-OprJ, and only 1 isolate overproduced MexJK. All the isolates overexpressed MexXY, while overexpression of MexEF-OprN and MexVW was common. DNA sequencing analysis of regulatory genes showed that no clear correlation could be established among (i) the presence of mutations, (ii) the type of mutations, (iii) the expression level of the Mex systems, and (iv) resistance to antibiotic substrates. The results suggest that the concomitant overexpression of some Mex systems may superimpose their antimicrobial drug efflux capabilities, contributing to the multidrug resistance phenotype in the P. aeruginosa non-CF clinical isolates. The existence of uncharacterized regulators for the Mex systems was signified.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
---|---|
Enthalten in: |
Canadian journal of microbiology - 60(2014), 7 vom: 07. Juli, Seite 437-43 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Poonsuk, Kanchana [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 28.09.2014 Date Revised 02.12.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1139/cjm-2014-0239 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM238990524 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM238990524 | ||
003 | DE-627 | ||
005 | 20231224114956.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1139/cjm-2014-0239 |2 doi | |
028 | 5 | 2 | |a pubmed24n0796.xml |
035 | |a (DE-627)NLM238990524 | ||
035 | |a (NLM)24909060 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Poonsuk, Kanchana |e verfasserin |4 aut | |
245 | 1 | 0 | |a Simultaneous overexpression of multidrug efflux pumps in Pseudomonas aeruginosa non-cystic fibrosis clinical isolates |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.09.2014 | ||
500 | |a Date Revised 02.12.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The purpose of this study was to examine expression and regulation of 6 multidrug efflux systems, including MexAB-OprM, MexCD-OprJ, MexEF-OprN, MexXY, MexJK, and MexVW, in 13 non-cystic fibrosis (CF) clinical isolates of Pseudomonas aeruginosa. These isolates displayed a high level of resistance to many clinically important antibiotics. Some isolates simultaneously overexpressed up to 4 different Mex systems, as determined by quantitative real-time reverse transcription PCR. None of the isolates overexpressed MexCD-OprJ, and only 1 isolate overproduced MexJK. All the isolates overexpressed MexXY, while overexpression of MexEF-OprN and MexVW was common. DNA sequencing analysis of regulatory genes showed that no clear correlation could be established among (i) the presence of mutations, (ii) the type of mutations, (iii) the expression level of the Mex systems, and (iv) resistance to antibiotic substrates. The results suggest that the concomitant overexpression of some Mex systems may superimpose their antimicrobial drug efflux capabilities, contributing to the multidrug resistance phenotype in the P. aeruginosa non-CF clinical isolates. The existence of uncharacterized regulators for the Mex systems was signified | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Pseudomonas aeruginosa | |
650 | 4 | |a multidrug efflux system | |
650 | 4 | |a multidrug resistance | |
650 | 4 | |a multirésistance aux médicaments | |
650 | 4 | |a système d’efflux polychimiothérapeutique | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Bacterial Outer Membrane Proteins |2 NLM | |
650 | 7 | |a Membrane Transport Proteins |2 NLM | |
650 | 7 | |a RNA, Bacterial |2 NLM | |
700 | 1 | |a Tribuddharat, Chanwit |e verfasserin |4 aut | |
700 | 1 | |a Chuanchuen, Rungtip |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Canadian journal of microbiology |d 1954 |g 60(2014), 7 vom: 07. Juli, Seite 437-43 |w (DE-627)NLM000001651 |x 1480-3275 |7 nnns |
773 | 1 | 8 | |g volume:60 |g year:2014 |g number:7 |g day:07 |g month:07 |g pages:437-43 |
856 | 4 | 0 | |u http://dx.doi.org/10.1139/cjm-2014-0239 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 60 |j 2014 |e 7 |b 07 |c 07 |h 437-43 |